Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Mol Cell Biol ; 26(23): 9060-70, 2006 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-16940177

RESUMEN

Gata4, a member of the zinc finger family of GATA transcription factors, is highly expressed in duodenum and jejunum but is nearly undetectable in distal ileum of adult mice. We show here that the caudal reduction of Gata4 is conserved in humans. To test the hypothesis that the regional expression of Gata4 is critical for the maintenance of jejunal-ileal homeostasis in the adult small intestine in vivo, we established an inducible, intestine-specific model that results in the synthesis of a transcriptionally inactive Gata4 mutant. Synthesis of mutant Gata4 in jejuna of 6- to 8-week-old mice resulted in an attenuation of absorptive enterocyte genes normally expressed in jejunum but not in ileum, including those for the anticipated targets liver fatty acid binding protein (Fabp1) and lactase-phlorizin hydrolase (LPH), and a surprising induction of genes normally silent in jejunum but highly expressed in ileum, specifically those involved in bile acid transport. Inactivation of Gata4 resulted in an increase in the goblet cell population and a redistribution of the enteroendocrine subpopulations, all toward an ileal phenotype. The gene encoding Math1, a known activator of the secretory cell fate, was induced approximately 75% (P < 0.05). Gata4 is thus an important positional signal required for the maintenance of jejunal-ileal identities in the adult mouse small intestine.


Asunto(s)
Factor de Transcripción GATA4/metabolismo , Íleon/citología , Mucosa Intestinal/fisiología , Intestino Delgado/citología , Yeyuno/citología , Animales , Técnica del Anticuerpo Fluorescente Directa , Factor de Transcripción GATA4/genética , Íleon/metabolismo , Integrasas/metabolismo , Mucosa Intestinal/citología , Intestino Delgado/metabolismo , Yeyuno/metabolismo , Ratones , Ratones Transgénicos , Modelos Biológicos
2.
J Pediatr Hematol Oncol ; 25(4): 297-302, 2003 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-12679643

RESUMEN

PURPOSE: To assess bone mineralization in adolescents with bone tumors at remission using quantitative digital ultrasound (QUS) and dual-energy x-ray absorptiometry (DEXA), and to compare the bone mineralization values obtained by both methods. METHODS: Patients studied were 36 adolescents (21 boys, 15 girls) who had completed treatment of a bone tumor at the University Hospital of the University of Navarra (Pamplona, Spain). QUS was performed at the distal metaphysis of the proximal phalanxes of the last four fingers of the nondominant hand. A DBM Sonic 1200 Ultrasound densitometer was used. DEXA measurements were made at the lumbar spine (vertebrae L1-L4) using the Hologic QDR 4500 W device. Calcium and vitamin D daily intake and grade of physical activity were recorded. RESULTS: Mean age at bone mineralization determination was 19.11 years. Disease-free survival was 4.97 years. Decreased bone mineralization was observed by both methods. Bone mineralization absolute values measured by QUS and DEXA were significantly correlated. The sensitivity, specificity, diagnostic accuracy, and positive and negative predictive values of QUS for predicting osteopenia were 36.4%, 80.0%, 66.7%, 44.4%, and 74.1%, respectively. Daily vitamin D intake was below the recommended dietary allowances. CONCLUSIONS: Adolescents in remission from bone tumors have low bone mineralization determined by DEXA or QUS.


Asunto(s)
Absorciometría de Fotón , Densidad Ósea , Enfermedades Óseas Metabólicas/etiología , Neoplasias Óseas/complicaciones , Dedos/diagnóstico por imagen , Vértebras Lumbares/diagnóstico por imagen , Osteosarcoma/complicaciones , Sarcoma de Ewing/complicaciones , Antineoplásicos/efectos adversos , Antineoplásicos/uso terapéutico , Desarrollo Óseo/efectos de los fármacos , Desarrollo Óseo/efectos de la radiación , Enfermedades Óseas Metabólicas/diagnóstico por imagen , Neoplasias Óseas/tratamiento farmacológico , Neoplasias Óseas/radioterapia , Neoplasias Óseas/cirugía , Huesos/metabolismo , Terapia Combinada , Supervivencia sin Enfermedad , Humanos , Minerales/metabolismo , Trastornos Nutricionales/complicaciones , Osteosarcoma/tratamiento farmacológico , Osteosarcoma/radioterapia , Osteosarcoma/cirugía , Valor Predictivo de las Pruebas , Radioterapia/efectos adversos , Sarcoma de Ewing/tratamiento farmacológico , Sarcoma de Ewing/radioterapia , Sarcoma de Ewing/cirugía , Sobrevivientes , Ultrasonografía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA